Bosentan first-line treatment in pulmonary arterial hypertension: long-term clinical outcome and echocardiographic and Doppler measures

被引：0
|
作者：
Loban, C. Fernandez-Gofin [1 ]
Escribano, P. [1 ]
Tello, R. [1 ]
Gutierrez, H. [1 ]
Sanchez, M. A. Gomez [1 ]
Delgado, J. [1 ]
Jimenez, C. [1 ]
de la Calzada, C. Saenz [1 ]
机构：
[1] Hosp 12 Octubre, E-28041 Madrid, Spain
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P588
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [1] Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
    Provencher, S
    Sitbon, O
    Humbert, M
    Cabrol, S
    Jaïs, X
    Simonneau, G
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (05) : 589 - 595
  • [2] Long-term outcomes in pulmonary arterial hypertension in the first-line epoprostenol or first-line bosentan era
    Jacobs, Wouter
    Boonstra, Anco
    Brand, Monika
    Rosenberg, Daniel M.
    Schaaf, Berthold
    Postmus, Pieter E.
    Noordegraaf, Anton Vonk
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (10): : 1150 - 1158
  • [3] LONG-TERM OUTCOME WITH FIRST-LINE BOSENTAN THERAPY IN SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
    Launay, D.
    Sitbon, O.
    Le Pavec, J.
    Savale, L.
    Tcherakian, C.
    Yaici, A.
    Achouh, L.
    Parent, F.
    Jais, X.
    Simonneau, G.
    Humbert, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S159 - S159
  • [4] Long-term outcome with first-line bosentan therapy in systemic sclerosis-associated pulmonary arterial hypertension
    Launay, David
    Sitbon, Olivier
    Jais, Xavier
    Yaici, Azzedine
    Le Pavec, Jerome
    Tcherakian, Colas
    Humbert, Marc
    Simonneau, Gerald
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S819 - S819
  • [5] Long-term bosentan treatment in children with pulmonary arterial hypertension
    Standing, JF
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1914 - 1915
  • [6] A Randomized Open Label Study Comparing First-Line Treatment With Bosentan Or Sildenafil In Pulmonary Arterial Hypertension (pah): Long-Term Results
    Mazzanti, G.
    Palazzini, M.
    Albini, A.
    Terzi, F.
    Bachetti, C.
    Conficoni, E.
    Monti, E.
    Gotti, E.
    Rizzo, N.
    Dardi, F.
    Rinaldi, A.
    Manes, A.
    Galie, N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases
    Girgis, RE
    Mathai, SC
    Krishnan, JA
    Wigley, FM
    Hassoun, PM
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (10): : 1626 - 1631
  • [8] Long-term bosentan treatment in children with pulmonary arterial hypertension - Reply
    Rosenzweig, EB
    Ivy, DD
    Widlitz, A
    Doran, A
    Claussen, LR
    Yung, D
    Abman, SH
    Barst, RJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1915 - 1915
  • [9] Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
    Launay, David
    Sitbon, Olivier
    Le Pavec, Jerome
    Savale, Laurent
    Tcherakian, Colas
    Yaici, Azzedine
    Achouh, Lara
    Parent, Florence
    Jais, Xavier
    Simonneau, Gerald
    Humbert, Marc
    [J]. RHEUMATOLOGY, 2010, 49 (03) : 490 - 500
  • [10] Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
    Hislop, A. A.
    Moledina, S.
    Foster, H.
    Schulze-Neick, I.
    Haworth, S. G.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) : 70 - 77
12345